NCI Center for Global Health Highlights Challenges of Conducting Cancer Trials in LMICs
NCI Center for Global Health shared on LinkedIn about a recent paper by Linsey Eldridge et al. published in Jama Network Open:
“Though key to testing the safety and efficacy of new cancer treatments, clinical trials do not always reflect the global burden of cancer.
A new study in JAMA Network Open surveyed clinicians with cancer therapeutic clinical trial experience in low- and middle-income countries, to determine common challenges faced when conducting trials in resource-constrained settings. Read more about these challenges and potential solutions to strengthen clinical trials in LMICs.”
Title: Barriers and Opportunities for Cancer Clinical Trials in Low- and Middle-Income Countries
Authors: Linsey Eldridge, Nina R. Goodman, Amina Chtourou, Annette Galassi, Cecilia Monge, Mishka Kohli Cira, Paul C. Pearlman, Patrick J. Loehrer Sr, Satish Gopal, Ophira Ginsburg
Other posts featuring NCI Center for Global Health on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023